文献速递耳科与耳神经

BPPV复位后残余头晕干预策略的单中心随机对照试验

[Intervention strategies for residual dizziness after successful repositioning maneuvers in benign paroxysmal positional vertigo: a single center randomized controlled trial].
PubMed 文献 · Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi · 2021-01-01

该单中心随机对照试验纳入129例BPPV成功复位后残余头晕患者,随机分为前庭康复组、倍他司汀组和对照组各43例。前庭康复可显著改善日常活动与社会参与功能(VAP评分),但对缩短残余症状持续时间和促进平衡功能恢复的效果尚不确定。

要点

  • 前庭康复可显著改善BPPV复位后残余头晕患者的日常活动与社会参与功能。
  • 倍他司汀对日常活动与社会参与功能的改善与对照组无统计学差异。
  • 前庭康复对缩短残余症状持续时间和促进平衡功能恢复的效果尚不确定。

核心结论

  • 前庭康复可以显著改善BPPV复位后残余症状患者的日常活动与社会参与功能。
  • 前庭康复对缩短残余症状持续时间和促进平衡功能恢复的效果尚不确定。

研究设计与样本

  • 采用平行、随机对照试验设计,2019年1—7月期间复旦大学附属眼耳鼻喉科医院收治的129例BPPV复位后有残余症状的患者在线完全随机化分至前庭康复组、倍他司汀组及对照组(空白),每组43例。
  • 前庭康复组接受为期4周的康复训练;倍他司汀组口服甲磺酸倍他司汀(12 mg/次,每日3次)4周;对照组无特殊处理。
  • 入组后4周、8周时随访,主要结局指标为前庭活动与参与量表(VAP)测量的日常活动与社会参与功能,次要指标为基于感觉统合试验(SOT)的平衡功能以及残余症状的持续天数。

主要发现

  • 三组患者VAP量表得分随时间推移均呈下降趋势,但前庭康复组下降幅度更为显著。
  • 前庭康复组与对照组VAP评分差异有统计学意义(B=-3.88,χ²=18.29,P<0.01);倍他司汀组与对照组差异无统计学意义(B=-0.96,χ²=1.16,P=0.28)。
  • 三组患者平衡功能随时间呈现恢复趋势,组间差异无统计学意义(χ²=1.37,df=2,P>0.05)。
  • 前庭康复组和倍他司汀组残余症状持续时间的中位数均为14 d,对照组为19 d,三组间差异无统计学意义[Log-rank(Mantel-Cox)test;χ²=1.82,df=2,P=0.40]。

临床怎么用

  • 对于BPPV成功复位后存在残余头晕的患者,可考虑采用前庭康复训练以改善日常活动与社会参与功能。
  • 倍他司汀口服(12 mg/次,每日3次,共4周)在改善日常活动与社会参与功能方面未显示优于对照。
  • 前庭康复对缩短残余症状持续时间和促进平衡功能恢复的效果尚不确定,临床决策需结合个体情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To compare the effects of different intervention strategies for the management of residual dizziness following successful canalith repositioning procedure (CRP) in patients with benign paroxysmal positional vertigo (BPPV). Methods: A total of 129 BPPV patients with residual dizziness following successful CRP were recruited during January 2019 and July 2019. They were randomly assigned into three groups with 43 cases in each group: the vestibular rehabilitation group received rehabilitation training for four weeks; betahistine group was given orally 12 mg betahistine three times a day for four weeks; and the control group had no specific treatment. The primary outcomes were daily activities and social participation assessed by the Vestibular Activities and Participation measure (VAP). Secondary outcomes includedbalance function assessed by sensory organization test (SOT) and the duration of residual symptoms. Stata15.0 software was used for statistical analysis. Results: The scores of VAP in the three groups decreased over time, but a more significant decrease was found in vestibular rehabilitation group. Further paired comparison showed that the difference between the vestibular rehabilitation group and the control group was of statistical significance (B=-3.88, χ2=18.29, P<0.01), while the difference between the betahistine group and the control group was not statistically significant (B=-0.96, χ2=1.16, P=0.28). The balance function of the three groups showed a trend of recovery over time, with no significant differences between groups (χ2=1.37, df=2, P>0.05). The median duration of residual dizziness for both vestibular rehabilitation and betahistine groups was 14 days, while that of control group was 19 days, with no significant difference between three groups[Log-rank (Mantel-Cox) test; χ2=1.82, df=2, P=0.40]. Conclusion: Vestibular rehabilitation can significantly improve the daily activities and social participation function in BPPV patients with residual symptoms following successful CRP, but its effects on shortening the duration of residual symptoms and promoting the recovery of balance function remain uncertain. 目的: 比较不同干预策略处理良性阵发性位置性眩晕(benign paroxysmal positional vertigo, BPPV)复位成功后残余症状的临床疗效。 方法: 采用平行、随机对照试验设计,2019年1—7月期间复旦大学附属眼耳鼻喉科医院收治的129例BPPV复位后有残余症状的患者在线完全随机化分至前庭康复组、倍他司汀组及对照组(空白),每组43例。前庭康复组接受为期4周的康复训练;倍他司汀组口服甲磺酸倍他司汀(12 mg/次,每日3次)4周;对照组无特殊处理。入组后4周、8周时随访,主要结局指标为日常活动与社会参与功能,采用前庭活动与参与量表(vestibular activities and participation measure,VAP)测量,次要指标为基于感觉统合试验(sensory organization test, SOT)的平衡功能以及残余症状的持续天数。采用STATA15.0软件进行统计学分析。 结果: 三组患者VAP量表得分随时间推移均呈下降趋势,但前庭康复组下降幅度更为显著。分组比较,前庭康复组与对照组差异有统计学意义(B=-3.88,χ²=18.29,P<0.01);倍他司汀组与对照组差异无统计学意义(B=-0.96,χ²=1.16,P=0.28)。三组患者平衡功能随时间呈现恢复趋势,组间差异无统计学意义(χ²=1.37,df=2,P>0.05);前庭康复组和倍他司汀组残余症状持续时间的中位数均为14 d,对照组为19 d,三组间差异无统计学意义[Log-rank (Mantel-Cox) test;χ²=1.82,df=2,P=0.40]。 结论: 前庭康复可以显著改善BPPV复位后残余症状患者的日常活动与社会参与功能,对缩短残余症状持续时间和促进平衡功能恢复的效果尚不确定。.

来源:Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wu PX, Liu JP, Wang WQ, et al. [Intervention strategies for residual dizziness after successful repositioning maneuvers in benign paroxysmal positional vertigo: a single center randomized controlled trial]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021. PMID: 33472301. doi:10.3760/cma.j.cn115330-20201109-00856

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。